Showing results (81-90 of 97) with videos related to
Sort By:
Pageof 10
American Journal of Hematology|February 8, 2025
Clinico-Genomic Interrogation of Secondary-Type Acute Myeloid Leukemia: Response and Outcomes to Contemporary TherapiesJayastu Senapati, Sanam Loghavi, Jennifer Marvin-Peek, et al.Cancer Immunology Research|June 7, 2023
Single-Cell Profiling of CD8+ T Cells in Acute Myeloid Leukemia Reveals a Continuous Spectrum of Differentiation and Clonal HyperexpansionPoonam N Desai, Bofei Wang, Andre Fonseca, et al.Cancer Immunology Research|May 10, 2023
Single-Cell Profiling of CD8+ T Cells in Acute Myeloid Leukemia Reveals a Continuous Spectrum of Differentiation and Clonal HyperexpansionPoonam N Desai, Bofei Wang, Andre Fonseca, et al.Cancer|May 6, 2026
Prognostic impact of ASXL1 mutations in acute myeloid leukemia treated with lower intensity therapyJennifer Marvin-Peek, Courtney D DiNardo, Sanam Loghavi, et al.Cancer|August 7, 2025
Contemporary outcomes of octa-nonagenarians with newly diagnosed acute myeloid leukemiaJayastu Senapati, Hagop M Kantarjian, Tapan M Kadia, et al.Nature Communications|December 7, 2021
The histologic phenotype of lung cancers is associated with transcriptomic features rather than genomic characteristicsMing Tang, Hussein A Abbas, Marcelo V Negrao, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2025
Outcomes of Frontline Triplet Regimens With a Hypomethylating Agent, Venetoclax, and Isocitrate Dehydrogenase Inhibitor for Intensive Chemotherapy-Ineligible Patients With Isocitrate Dehydrogenase-Mutated AMLCourtney D DiNardo, Jennifer Marvin-Peek, Sanam Loghavi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 11, 2026
The All-Oral Combination of Revumenib, Decitabine and Venetoclax for Relapsed or Refractory Acute Myeloid Leukemia (SAVE)Ghayas C Issa, Branko Cuglievan, Georgina El Hajjar, et al.Nature Communications|February 28, 2024
Comprehensive characterization of IFNγ signaling in acute myeloid leukemia reveals prognostic and therapeutic strategiesBofei Wang, Patrick K Reville, Mhd Yousuf Yassouf, et al.Nature Communications|October 19, 2021
Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapyHussein A Abbas, Dapeng Hao, Katarzyna Tomczak, et al.Pageof 10